Llwytho...
Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?
Glaucoma is the second most common cause of blindness, affecting 70~80 million people around the world. The death of retinal ganglion cells (RGCs) is the main cause of blindness related to this disease. Current therapies do not provide enough protection and regeneration of RGCs. A novel opportunity...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Int J Stem Cells |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Korean Society for Stem Cell Research
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5741193/ https://ncbi.nlm.nih.gov/pubmed/28844129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15283/ijsc17029 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|